Download Files:
GSK-3/CDK5/CDK2-IN-1
SKU
HY-134622-10 mg
Category Reference compound
Tags Cancer; Neurological Disease, CDK;GSK-3, Cell Cycle/DNA Damage;PI3K/Akt/mTOR;Stem Cell/Wnt
$350 – $2,500
Products Details
Product Description
– GSK-3/CDK5/CDK2-IN-1, an imidazole derivative, is an inhibitor of cdk5, cdk2, and GSK-3 extracted from patent WO2002010141A1, example 9a. GSK-3/CDK5/CDK2-IN-1 can be used for the research of cancer, and neurodegenerative diseases[1].
Web ID
– HY-134622
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C21H22N4O2
References
– [1]Ahlijanian MK, et, al. Preparation of acylaminoimidazoles as inhibitors of cdk5, cdk2, and GSK-3. WO2002010141A1.
CAS Number
– 395074-72-3
Molecular Weight
– 362.42
Compound Purity
– 98.56
SMILES
– O=C(NC1=CN([C@H]2C[C@@H](NC(C)=O)C2)C=N1)CC3=CC=C4C=CC=CC4=C3
Clinical Information
– No Development Reported
Research Area
– Cancer; Neurological Disease
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– CDK;GSK-3
Pathway
– Cell Cycle/DNA Damage;PI3K/Akt/mTOR;Stem Cell/Wnt
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.